AI assistant
Sending…
HERON THERAPEUTICS, INC. /DE/ — Director's Dealing 2012
Sep 12, 2012
33572_dirs_2012-09-12_377e73b3-f8d4-4df2-b92a-74f1d23911c6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AP PHARMA INC /DE/ (APPA)
CIK: 0000818033
Period of Report: 2012-07-25
Reporting Person: SPCH, LLLP (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-07-25 | A.P. Pharma Common Stock | P | 38095238 | $0.525 | Acquired | 38095238 | Direct |
More from HERON THERAPEUTICS, INC. /DE/
Regulatory Filings
2026
Jun 2
Major Shareholding Notification
2026
May 13
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Annual Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Regulatory Filings
2026
Apr 20
Board/Management Information
2026
Apr 6
Major Shareholding Notification
2026
Mar 27